BlackRock’s Alexion Pharmaceuticals ALXN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | – | Sell |
|
|||||
|
2021
Q2 | $3.21B | Sell |
|
|||||
|
2021
Q1 | $2.68B | Sell |
|
|||||
|
2020
Q4 | $2.84B | Buy |
|
|||||
|
2020
Q3 | $2.07B | Sell |
|
|||||
|
2020
Q2 | $2.08B | Buy |
|
|||||
|
2020
Q1 | $1.48B | Buy |
|
|||||
|
2019
Q4 | $1.72B | Sell |
|
|||||
|
2019
Q3 | $1.56B | Sell |
|
|||||
|
2019
Q2 | $2.13B | Buy |
|
|||||
|
2019
Q1 | $2.17B | Sell |
|
|||||
|
2018
Q4 | $1.58B | Sell |
|
|||||
|
2018
Q3 | $2.27B | Buy |
|
|||||
|
2018
Q2 | $2.02B | Sell |
|
|||||
|
2018
Q1 | $1.99B | Sell |
|
|||||
|
2017
Q4 | $2.15B | Sell |
|
|||||
|
2017
Q3 | $2.72B | Sell |
|
|||||
|
2017
Q2 | $2.42B | Buy |
|
|||||
|
2017
Q1 | $2.26B | Buy |
|
|||||
|
2016
Q4 | $81.7M | Buy |
|
|||||
|
2016
Q3 | $79.6M | Buy |
|
|||||
|
2016
Q2 | $58.5M | Buy |
|
|||||
|
2016
Q1 | $69M | Sell |
|
|||||
|
2015
Q4 | $133M | Sell |
|
|||||
|
2015
Q3 | $112M | Buy |
|
|||||
|
2015
Q2 | $127M | Buy |
|
|||||
|
2015
Q1 | $114M | Buy |
|
|||||
|
2014
Q4 | $120M | Buy |
|
|||||
|
2014
Q3 | $104M | Sell |
|
|||||
|
2014
Q2 | $100M | Sell |
|
|||||
|
2014
Q1 | $103M | Buy |
|
|||||
|
2013
Q4 | $73.2M | Buy |
|
|||||
|
2013
Q3 | $46.6M | Sell |
|
|||||
|
2013
Q2 | $39.3M | Buy |
|